International Journal of Neuropsychopharmacology

Article	Citations
Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study	130
PSYCHOLOGICAL ANALYSIS OF ENVIRONMENTAL FACTORS OF OIL SPILL IN SHENZHEN PORT	75
A QUESTIONNAIRE SURVEY ON THE RELATIONSHIP BETWEEN EARLY ART EDUCATION AND EMOTION REGULATION OF CHINESE COLLEGE STUDENTS	73
THE INFLUENCE OF ENTREPRENEURIAL EFFECT ON ENTREPRENEURSHIP FROM THE PERSPECTIVE OF EMOTIONAL BEHAVIOR CHANGE	61
MENTAL HEALTH STATUS AND EMOTIONAL BEHAVIOR REGULATIONOF SCI-TECH JOURNAL EDITORS AND ITS IMPACT ON JOURNAL QUALITY	59
STUDY ON THE INFLUENCE OF INTELLIGENT TEACHING MODE BASED ON EMOTION REGULATION ON THE TEACHING QUALITY OF AGRICULTURAL METEOROLOGY	45
RESEARCH ON THE RELATIONSHIP BETWEEN THE NEW MODEL OF STATE-OWNED ENTERPRISE REFORM AND PSYCHOLOGICAL IDENTITY AND EMOTIONAL REGULATION	42
REGIONAL HOMOGENEITY CHANGES IN CEREBRAL AND CEREBELLAR REGIONS ASSOCIATED WITH DEFAULT-MODE NETWORK FOLLOWING PROLONGED INTERMITTENT THETA-BURST STIMULATION	39
PROTOTYPIC ANTIDEPRESSANTS ACT AS A G-PROTEIN BIASED LPAR1 AGONIST AND CONTRIBUTE TO ANTIDEPRESSANT EFFECTS	35
COURAGE AND TRANSFORMATION: PATIENT EXPERIENCES OF WEB- BASED EMDR FOR SUICIDAL IDEATION	34
CB2 RECEPTOR IS ONE OF THE REGULATORY FACTORS OF THE AGE- RELATED CHANGES IN IMMUNE MECHANISM	34
INHIBITION OF HISTAMINE METABOLIZING ENZYME IN THE BRAIN REDUCES CATAPLEXY IN NARCOLEPSY MODEL MICE	30
NEURAL ACTIVITY CHANGES VIA DOPAMINE D1 RECEPTOR STIMULATION IN THE NUCLEUS ACCUMBENS MODULATE MOTIVATION FOR WHEEL RUNNING IN MICE	29
(2R,6R)-HYDROXYNORKETAMINE TARGETING THE BASOLATERAL AMYGDALA REGULATES FEAR MEMORY	28
FUNCTIONAL ANALYSIS OF IPS CELL-DERIVED NEURONS FROM A PATIENT WITH 3Q29 DELETION	27
CONTRIBUTION OF 5-HT2AR TO THE ANTI-ANHEDONIC AND NEUROPLASTICITY EFFECTS OF PSYCHEDELICS	26
DORSAL CA3 NEURAL ACTIVITY MEDIATES WITNESSING STRESS- INDUCED RECOGNITION MEMORY DEFICITS IN ADOLESCENT MALE MICE	26
GUSHANSKAYA EKATERINA VLADIMIROVNA, PSYCHIATRIST, PSYCHOTHERAPIST, CANDIDATE OF MEDICAL SCIENCES, HEAD OF THE DEPARTMENT OF PSYCHIATRY AT THE PSYCHIATRIC HOSPITAL 13, ASSOCIATE PROFESSOR OF THE DEPART	25
POSSIBLE IMMUNOLOGICAL PATHOPHYSIOLOGY IN BIPOLAR DISORDER: REVERSE-TRANSLATIONAL RESEARCH USING INDUCED MICROGLIA-LIKE (IMG) CELLS	24
DEPRESSION AND ANTIDEPRESSANT USE IN PREGNANCY AND ADVERSE MATERNAL AND FETAL/CHILDREN OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS	23
EVENAMIDE AS ADD-ON TREATMENT FOR TREATMENT-RESISTANT SCHIZOPHRENIA (TRS) PATIENTS NOT BENEFITING FROM ANTIPSYCHOTICS: DESIGN OF A PHASE 3, POTENTIALLY PIVOTAL, INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND	22
FACTORS ASSOCIATED WITH THE INITIATION OF LAXATIVE USE IN THE SAME PATIENTS WITH SCHIZOPHRENIA OVER A 20-YEAR PERIOD: RETROSPECTIVE COHORT STUDY	20
EFFECTS OF MULTIPLE NEUROPSYCHIATRIC MEDICATIONS DURING PREGNANCY ON NEONATAL ABSTINENCE SYNDROME (SECOND REPORT)	20
IGF-1 Microinjection in the Prefrontal Cortex Attenuates Fentanyl-Seeking Behavior in Mice	19
A Meta-Analysis of Neural Correlates of Reward Anticipation in Individuals at Clinical Risk for Schizophrenia	19

NPAS4 ENHANCER RNA FORMS DNA:RNA HYBRID R-LOOP TO CONTROL REWARD-RELATED BEHAVIORAL ADAPTATION THROUGH ACTIVITY-DEPENDENT GENE EXPRESSION	19
Aromatase Inhibition and Electroconvulsive Seizures in Adolescent Rats: Antidepressant and Long-Term Cognitive Sex Differences	19
Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice	18
EXPLORATION OF LANDSCAPE PAINTING IN THE TREATMENT OF ANXIETY DISORDER IN ART EDUCATION	18
303. PATIENT AND CLINICIAN ACCEPTANCE OF RECENT TECHNOLOGICAL ADVANCES IN THE THERAPEUTIC MONITORING OF LITHIUM	17
Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response	17
589. PERIPUBERTAL STRESS EXERTS DIFFERENTIAL IMPACTS ON THALAMIC RETICULAR AND REUNIENS NUCLEI IN MALE VS FEMALE RATS	17
680. ASSESSING THE UTILITY OF ZURANOLONE TO MODIFY ALCOHOL-RELATED BEHAVIOURS	16
267. ETHNIC VARIABILITY IN RTMS DOSAGE: A CALL FOR ADAPTIVE THERAPEUTIC INNOVATION	15
466. ASSESSING AND MANAGING CIGARETTE SMOKING AMONG PSYCHIATRIC INPATIENTS: CLINICAL AND SOCIODEMOGRAPHIC IMPLICATIONS	15
260. INSULIN-LIKE GROWTH FACTOR 1 IN THE BRAIN AND ADDICTION --- THE VULNERABLE PREFRONTAL CORTEX IN OPIOID USE DISORDER	15
272. EFFECTIVENESS OF TRANSCRANIAL PULSE STIMULATION FOR MAJOR DEPRESSION: PRELIMINARY EVIDENCE FOR CLINICAL RESPONSE AND NEUROIMAGING MECHANISMS	15
329. DIFFERENTIALLY EXPRESSED PLATELET ONCOPROTEINS AND THEIR ASSOCIATION WITH PLASMA PROGRAMMED CELL DEATH LIGAND 1 IN BIPOLAR MANIC PATIENTS	15
495. USING SPATIALLY RESOLVED SINGLE-NUCLEUS MULTI-OMICS APPROACH TO UNDERSTAND HOW ADVERSITY CONTRIBUTES TO PSYCHIATRIC DISORDERS	15
370. ASSOCIATIONS OF POLYGENIC RISK SCORES DIFFERENTIATING ATTENTION-DEFICIT HYPERACTIVITY DISORDER FROM AUTISM SPECTRUM DISORDER WITH COGNITIVE AND CORTICAL ALTERATIONS IN SCHIZOPHRENIA PATIENTS	14
467. THE NEUROANATOMY OF POSTPARTUM DEPRESSION: INSIGHTS FROM A CROSS-SECTIONAL STRUCTURAL MRI STUDY	14
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression	14
328. DELAYED ONSET POST-STROKE MANIA, A CASE REPORT AND LITERATURE REVIEW	14
Inflammatory Process and Immune System in Major Depressive Disorder	13
DEVELOPMENT OF A MULTIMODAL VR SYSTEM FOR CORTICAL FUNCTIONAL NETWORK ANALYSIS DURING MOUSE SOCIAL BEHAVIOR	13
ASSOCIATION BETWEEN ALLOSTATIC LOAD AND CARDIAC STRUCTURE IN ADULT PATIENTS WITH SCHIZOPHRENIA	13
Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms	13
PSYCHOSOMATIC SYMPTOMS IN TYPE 2 DIABETES PATIENTS: A NETWORK ANALYSIS	13
TREATMENT DISENGAGEMENT AND APD TREATMENT IN EARLY PSYCHOSIS: RESULTS FROM EPINET – THE LARGEST EP NETWORK IN THE USA	13
A STUDY ON THE REGULATORY STATUS OF PSYCHEDELICS IN KOREA AND THEIR ADMISSIBILITY AS THERAPEUTIC AGENTS	13
SOCIAL INTERACTION SUPPRESSES COCAINE RELAPSE BY REGULATING DAERGIC ENGRAM INPUT OF VENTRAL TEGMENTAL AREA	13
THE INFLUENCE OF FAMILY CULTURAL CAPITAL ON MIGRANT CHILDREN'S ACADEMIC ACHIEVEMENT — FROM THE PERSPECTIVE OF EMOTIONAL REGULATION	12
EXPLORATION OF MOBILE MARKET: POPULATION DISTRIBUTION AND EMOTIONAL BEHAVIOR CHANGES IN SOUTHEAST AND SOUTH ASIAN COUNTRIES	12
THE IMPACT OF BALANCING DOMESTIC AND FOREIGN TAX SYSTEMS ON ALLEVIATING TAXPAYERS' INEQUALITY AND ANXIETY	12
IDENTIFICATION OF PSYCHOLOGICAL COMPLEXITY AND EMOTIONAL REGULATION FACTORS OF CONSTRUCTION PROJECTS IN CHINA	12
WHAT IS RELATED TO COST, PRODUCT OR SERVICE - EMPIRICAL DATA AND MARKET SENTIMENT REGULATION ANALYSIS OF SERVICE-ORIENTED LISTED COMPANIES IN CHINA'S MANUFACTURING INDUSTRY	12
CANNABINOID RECEPTOR TYPE 1-REGULATED CELL DEATH DEPENDING ON ITS SUBCELLULAR LOCALIZATION IN HUMAN NEUROBLASTOMA CELL	12
RESEARCH ON CATERING SERVICE ENCOUNTER, RELATIONSHIP BENEFIT AND CUSTOMER VOLUNTARY PERFORMANCE FROM THE PERSPECTIVE OF EMOTIONAL BEHAVIOR CHANGE -- A CASE STUDY OF CATERING CONSUMERS IN TAIWAN AND MA	12
EXPLORING AND CONSTRUCTING AN EFFECTIVE EVALUATION MODEL OF NETWORK TEACHING FROM THE PERSPECTIVE OF EMOTION REGULATION	12
DISTRIBUTION OF DOPAMINE PATHWAY GENE POLYMORPHISMS IN SUBJECTS WITH DIFFERENT SMOKING BEHAVIOR	12
Vorinostat Corrects Cognitive and Non-Cognitive Symptoms in a Mouse Model of Fragile X Syndrome	11
176. ANALYSIS OF THE EFFECT OF OXYTOCIN ANALOGUES ON A MOUSE CONTEXTUAL FEAR-CONDITIONING BEHAVIOR	11
163. RELATIONSHIP BETWEEN CLOZAPINE: NORCLOZAPINE RATIO AND COGNITIVE FUNCTION AND EMPLOYMENT STATUS IN TREATMENT RESISTANT SCHIZOPHRENIA	11
522. TARGETING OPIOID NEUROTRANSMISSION IN BORDERLINE PERSONALITY DISORDER WITH SELF-HARMING BEHAVIOR: PRELIMINARY FINDINGS OF A [11C]NOP-1A POSITRON EMISSION TOMOGRAPHY STUDY	11
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3	11
233. DYNAMIC POSTURAL CONTROL IN REMITTED BIPOLAR I DISORDER: A CDP STUDY	11
Adjunctive Brexpiprazole in Patients With Unresolved Symptoms of Depression on Antidepressant Treatment Who are Early in the Disease Course: Post Hoc Analysis of Randomized Controlled Trials	11
The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion	11
108. SELECTIVE POTENTIATION OF α5-GABAA RECEPTORS CONTRIBUTES TO REDUCTION OF COGNITIVE BURDEN AND NEURONAL LOSS IN AGING MICE	11
160. CHANGES IN QUALITY OF LIFE AND PRODUCTIVITY GAIN AMONG ESKETAMINE RESPONDERS IN A REAL-WORLD STUDY IN AUSTRALIA AND NEW ZEALAND	11
Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies	10
421. THE RELATIONSHIP BETWEEN SLEEP QUALITY AND NEUROCOGNITIVE FUNCTION IN THE GERIATRIC DEPRESSION: A CASE-CONTROL STUDY	10
A STUDY ON THE CORRELATION BETWEEN PSYCHOLOGICAL ANXIETY, SELF-EFFICACY AND FOREIGN LANGUAGE LEARNING ACHIEVEMENT	10
388. COMMON AND DISTINCT EFFECTS OF 10-HZ RTMS AND ITBS ON STRIATUM-BASED FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER: A SHAM-CONTROLLED STUDY	10
Default Mode Network Modulation by Psychedelics: A Systematic Review	10

545. DEFICIENCY OF TBX1, A GENE ENCODED IN 22Q11.2 COPY NUMBER VARIATION, IMPAIRS SOCIAL AND COGNITIVE BEHAVIORS BY ALTERING BRAIN SHAPE AND NEONATAL STEM CELLS	10
Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls	9
EXPLORATION ON THE TEACHING REFORM OF “X-Y THEORY” IN THE DESIGN COURSE OF ENVIRONMENTAL DESIGN SPECIALTY BASED ON EMOTION REGULATION	9
EFFICACY EVALUATION OF TELEMEDICINE-BASED BIOPSYCHOSOCIAL MODEL: A RETROSPECTIVE STUDY IN CENTRAL CHINA	9
Metabotropic Glutamate Receptor 5 as a Potential Biomarker of the Intersection of Trauma and Cannabis Use	9
A DIACHRONIC CASE STUDY OF ENGLISH TEACHERS' ONLINE EMOTION REGULATION	9
ON THE LONG-TERM CONSTRUCTION OF IDEOLOGICAL AND POLITICAL EDUCATION SYSTEM IN COLLEGES AND UNIVERSITIES GUIDED BY THE STATUS AND VALUES OF NATIONAL SENIOR OFFICIALS—BASED ON STUDENTS' EMOTIONAL BEHAV	9
STUDY ON CIVIL LITIGATION PSYCHOLOGY AND LEGAL IDENTITY FROM THE PERSPECTIVE OF EMOTIONAL BEHAVIOR REGULATION	9
EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION OF THE LEFT DORSOLATERAL PREFRONTAL CORTEX ON SYMPTOM DOMAINS IN MOOD DISORDERS	9
EFFICACY OF LOW-DOSE INTERLEUKIN 2 AS ADD-ON IN THE TREATMENT OF UNIPOLAR AND BIPOLAR DEPRESSION	8
PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?	8
Investigation of Neurofunctional Changes Over the Course of Electroconvulsive Therapy	8
THE IOWA GAMBLING TASK NET SCORES IS ASSOCIATED WITH SOCIAL FUNCTION IN BIPOLAR DISORDER	8
ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITAN	8
ANTI DIABETIC PERIPHERAL NEUROPATHY OF RED FRUIT (PANDANUS CONOIDES LAMK) OIL IN A RAT MODEL: INVOLVEMENT OF OXIDATIVE AND NEUROINFLAMMATORY PATHWAYS	8
CONNEXIN43 IN NEONATAL EXCITATORY NEURONS IS IMPORTANT FOR MOTOR LEARNING	8
Effect ofMAOADNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission Tomography	8
BASED ON ANXIETY SENSITIVITY AND ANXIETY INHIBITION: RECONSTRUCTION OF POST APOCALYPTIC SOCIETY	8
EXPLORING THE NEUROBIOLOGICAL AND PSYCHOLOGICAL MECHANISMS OF KETAMINE IN PROBLEMATIC GAMBLING: A MECHANISTIC STUDY	8
IMPACT OF ANTIPSYCHOTICS ON PROLACTIN LEVELS IN PEDIATRIC AND ADOLESCENT PATIENTS WITH PSYCHIATRIC DISORDERS IN REAL-WORLD PSYCHIATRIC CLINICAL PRACTICE	8
A RETROSPECTIVE COMPARATIVE STUDY OF CLINICAL RESPONSE TO CLOZAPINE BETWEEN PATIENTS WITH EARLY TREATMENT-RESISTANT SCHIZOPHRENIA (TRS) AND LATE TRS	8
IMPLICIT MEMORY AND EXPLICIT MEMORY PROFILES COMPARISONS BETWEEN PATIENTS WITH DIFFERENT MOOD DISORDERS	8
A SURVEY OF PATIENT– PHYSICIAN COMMUNICATION REGARDING TREATMENT PROSPECTS AND GOAL SETTING IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN JAPAN	8
ANALYSIS OF DOPAMINE TRANSPORTER-EXPRESSING NEURON-SPECIFIC TYROSINE HYDROXYLASE KNOCKOUT MICE	8
Corrigendum to: Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior	8
RESEARCH ON YANGQIN PERFORMANCE OF HUNAN OPERA BASED ON THE COMBINATION OF HUTONG CULTURAL DEVELOPMENT AND STREET ART — FROM THE PERSPECTIVE OF EMOTION REGULATION	8
EFFECTIVENESS AND SAFETY OF BLONANSERIN FOR IMPROVING SOCIAL AND COGNITIVE FUNCTIONS IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA	8
DEVELOPMENTAL NICOTINE EXPOSURE AND COGNITIVE VULNERABILITY: IS THE IMMUNE SYSTEM INVOLVED?	8
PREDICTION OF CLINICAL RESPONSE TO DONEPEZIL AND MEMANTINE IN PATIENTS WITH ALZHEIMER'S DISEASES BY USING EEG CONNECTIVITY	8
MATERNAL EXPOSURE TO AIR POLLUTANT PM2.5 INDUCES AUTISTIC-LIKE BEHAVIOR IN OFFSPRING	8
PLASMA PHOSPHOETHANOLAMINE LEVELS AS A BIOMARKER FOR MONITORING MAJOR DEPRESSIVE DISORDER	7
ET-1-INDUCED ATTENUATION OF MOR ACTIVITY DIFFERS BETWEEN MORPHINE AND FENTANYL	7
ACTIVATION OF PREFRONTAL PARVALBUMIN INTERNEURONS AMELIORATES WORKING MEMORY DEFICIT EVEN UNDER CLINICALLY COMPARABLE ANTIPSYCHOTIC TREATMENT IN A MOUSE MODEL OF SCHIZOPHRENIA	7
Erythrocyte Membrane Fatty Acid Composition as a Potential Biomarker for Depression	7
PSYCHOPHARMACOLOGICAL CHALLENGES FOR HIV/AIDS PATIENTS WITH A HISTORY OF SUBSTANCE USE DISORDER EXPERIENCING PSYCHOTIC DEPRESSION	7
EFFECTS ON THE THALAMUS AND INSULAR CORTEX DURING VOCAL EMOTION PROCESSING BY MODAFINIL AND BUPROPION: A PHARMACOLOGICAL MRI STUDY	7
KNOCKDOWN OF CONNEXIN43 POTENTIATES ANTIDEPRESSANT EFFECT ON BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN PRIMARY CULTURED ASTROCYTES	7
JOBS STRESS LEADS TO PROFESSIONAL BURNOUT IN ADDICTION SPECIALISTS	7
ESTIMATING A PROBABILITY OF REDUCING RISKS ASSOCIATED WITH SMOKING CONVENTIONAL CIGARETTES USING THE THS2.2 (IQOS) TECHNOLOGY	7
TNFR2 LEVEL CHANGES IN PATIENTS WITH ALCOHOL DEPENDENCE DURING EARLY WITHDRAWAL	7
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers	7
Therapeutic potential of D-amino acid oxidase inhibitors for cognitive impairment associated with schizophrenia: learnings from luvadaxistat	6
255. UNVEILING THE COGNITIVE ENHANCING EFFECTS OF RS-D7, A NOVEL NDMAR MODULATOR, ON HIPPOCAMPUS-DEPENDENT LEARNING AND MEMORY IN MICE	6
548. DECODING THE BIOMOLECULAR LANDSCAPE OF PSYCHIATRIC DISORDERS FOR IMPROVING PATIENT STRATIFICATION	6
564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA	6
ANALYSIS ON THE CHANGES OF WOMEN'S ROLE EMOTION AND BEHAVIOR IN VARIOUS SOCIAL ACTIVITIES IN THE MING AND QING DYNASTIES	6
415. SHARED GENETIC ARCHITECTURES BETWEEN METHAMPHETAMINE USE AND OTHER PSYCHIATRIC DISORDERS	6
661. A SINGLE DOSE OF LYSERGIC ACID DIETHYLAMIDE (LSD) REDUCES ALCOHOL CONSUMPTION AND REVERTS DOPAMINERGIC (DA) DISFUNCTION IN MALE MICE	6
Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling	6
211. C-REACTIVE PROTEIN AND RESPONSE TO ADD-ON DEXTROMETHORPHAN TREATMENT IN BIPOLAR DISORDERS: RESULTS FROM A PLACEBO-CONTROLLED TRIAL	6
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine	6
458. EFFECTIVENESS OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE ON RELAPSE PREVENTION OF SCHIZOPHRENIA	6
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System	6
401. EXPLORING FUNCTIONAL CONNECTIVITY IN ANXIETY: THE ROLE OF THE HIPPOCAMPUS, INSULA, AND AMYGDALA DURING A KETAMINE INFUSION	6
618. A RANDOMISED CONTROLLED TRIAL OF AN AI-ENABLED MENTAL HEALTH INTERVENTION FOR GENERALIZED ANXIETY DISORDER SYMPTOMS	6
578. COLLECTING AND EVALUATING ANIMAL MODELS IN MENTAL HEALTH SCIENCE AND BUILDING AN ONLINE RESOURCE FOR RESEARCHERS: A WELLCOME INITIATIVE	6
543. MODULATION OF BRAIN FUNCTIONS BY GLIAL RESET	6
KNOWLEDGE AND OPINIONS ABOUT THE USE OF PSYCHEDELICS AMONG PSYCHIATRISTS IN KOREA: PRELIMINARY RESULTS	5
PLASMA GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) IN ASTROCYTES CONTRIBUTES TO INCREASES IN THE PREVALENCE OF AUTISM SPECTRUM DISORDERS (ASD)	5
ROLES OF CANNABINOID TYPE 1 RECEPTORS IN THE MICE PREFRONTAL CORTEX FOR OBJECT LOCATION MEMORY	5
EFFECTS OF ANTIPSYCHOTIC USE BY PATIENTS WITH SCHIZOPHRENIA ON DECELERATION CAPACITY AND ITS RELATION TO THE CORRECTED QT INTERVAL	5
GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION	5
MANIC BEHAVIOR MAY BE ATTENUATED BY MATRIX METALLOPROTEINASE-8 INHIBITOR VIA DECREASING NEUROINFLAMMATION IN A MOUSE MODEL OF BIPOLAR DISORDER	5
AN INSIGHT INTO GENETIC CONDITIONS ASSOCIATED WITH INTELLECTUAL DISABILITY IN INDONESIAN POPULATION	5
THE FUNCTIONAL CONNECTIVITY CHANGES OF THE RIGHT AMYGDALA ASSOCIATED WITH ANXIETY IN SCHIZOPHRENIA AND THE PRODROMAL PHASE	5
DISRUPTION OF IMPULSIVITY BEHAVIORS IN CANNABIS USERS IN ADOLESCENTS AND YOUNG ADULTS: A META-ANALYSIS OF FUNCTIONAL NEUROIMAGING STUDIES	5
THE NEURAL MECHANISM UNDERLYING THE ANTIDEPRESSANT EFFECTS ELICITED BY A SINGLE BOUT OF PHYSICAL EXERCISE	5
THE INFLUENCE OF DISSOCIATIVE RESPONSE ON CORTISOL LEVEL FOLLOWING CHILDHOOD AND LATER TRAUMA: A PATH ANALYSISTHE INFLUENCE OF DISSOCIATIVE RESPONSE ON CORTISOL LEVEL FOLLOWING CHILDHOOD AND LATER TRA	5
PROLINE-RICH TRANSMEMBRANE PROTEIN 2 KNOCK-IN MICE PRESENT NIGROSTRIATAL DOPAMINERGIC HYPERACTIVITY AND INCREASED SUSCEPTIBILITY TO L-DOPA-INDUCED MOTOR DEFICITS	5
PUTATIVE SEX DIFFERENCES IN THE EXCITABILITY OF BETA- ENDORPHIN AND NEUROPEPTIDE-Y-SECRETING NEURONS OF THE ARCUATE NUCLEUS	5
POGZ MUTANT MOUSE MODEL OF AUTISM SPECTRUM DISORDER SHOWS ABNORMAL NEURAL ACTIVITY IN THE ANTERIOR CINGULATE CORTEX DURING SOCIAL BEHAVIOR	5
DOES COCAINE-INDUCED AGGRAVATION OF DEPRESSION ALTER MATE ATTRACTIVENESS IN MALES?	5
REGULATION OF THE TRANSITION BETWEEN MEMORY RECALL AND NON- RECALL BY HISTAMINE NEURON ACTIVITY	5
LUMATEPERONE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER WITH ANXIOUS DISTRESS AND MIXED FEATURES	4
RTMS OVER THE DORSOLATERAL PREFRONTAL CORTEX INCREASES THE SERUM PROBDNF/BDNF RATIO: A SHAM-CONTROLLED STUDY IN SUBJECTS WITH COCAINE USE DISORDER	4
BLUNTED CORTISOL RESPONSE TO ACUTE PSYCHOSOCIAL STRESS IN WOMEN WITH PREMENSTRUAL DYSPHORIC DISORDER	4
Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress–Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling	4
Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach	4
THE SUCROSE INTAKE CHANGES STRESS-INDUCED BEHAVIOR VIA GLUCOSE METABOLISM AND NORADRENERGIC NEURONAL SYSTEM	4
THE IMPACT OF SLEEP JET LAG ON DEPRESSION DIFFERED BY SEX AND AGE ~ EVIDENCE FROM 27,916 TAIWAN BIOBANK PARTICIPANTS	4

From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from cl	4
Activation of mTORC1 Signaling Cascade in Hippocampus and Medial Prefrontal Cortex Is Required for Antidepressant Actions of Vortioxetine in Mice	4
Inhibition of hippocampal or thalamic inputs to the nucleus accumbens reverses stress-induced alterations in dopamine system function	4
ADJUVANT CITHICOLINE AGAINST NEGATIVE SYMPTOMPS AND INTERLEUKIN 6 (IL-6) IN SCHIZOPHRENIA PATIENTS WITH RECEIVING RISPERIDONE TREATMENT	4
ANXIETY-LIKE BEHAVIOUR STUDY IN ADULT RAT STRESS MODEL INDUCED BY LIGHT DOMINANT EXPOSURE IN CIRCADIAN RHYTHM DISRUPTION	4
IRON DEPOSITIONS IN PREFRONTAL CORTEX INFLUENCES THE EFFECTIVENESS OF CORTICAL PAIRED ASSOCIATIVE STIMULATION IN HEROIN-DEPENDENT PATIENTS: A RANDOMIZED SHAM-CONTROLLED STUDY	4
AGE OF ONSET AFFECTS RELAPSE OF ALCOHOL USE DISORDER: A 7- YEAR RETROSPECTIVE COHORT STUDY	4
Antipsychotics, COVID-19, and Secondary Healthcare Databases: Revisiting the Pandemic	4
VALUABLE INTERACTION WITH COGNITIVE REMEDIATION AND OPTIMAL ANTIPSYCHOTICS FOR RECOVERY IN SCHIZOPHRENIA (VICTORY-S): STUDY PROTOCOL FOR AN INTERVENTIONAL, OPEN-LABEL, RATER- BLINDED, RANDOMIZED COMPA	4
CAUSAL ASSOCIATIONS BETWEEN SCHIZOPHRENIA AND CANCERS: MENDELIAN RANDOMIZATION ANALYSES	3
209. OXYTOCINERGIC INPUT FOXYTOCINERGIC INPUT FROM THE PARAVENTRICULAR NUCLEUS TO THE NUCLEUS ACCUMBENS CORE MODULATES METHAMPHETAMINE-CONDITIONED PLACE PREFERENCE	3
601. GENETIC POLYMORPHISMS ASSOCIATED WITH OPIOID SENSITIVITY IN PATIENTS UNDERGOING PALLIATIVE CARE AND GENERAL ANAESTHESIA	3
CONSTRUCTION OF MULTIMODAL HEALING SPACE BASED ON INDIVIDUAL EMOTIONAL BEHAVIOR CHANGES	3
268. THE PRELIMINARY ANALYSIS OF YOGA THERAPY ON BURNOUT AMONG MEDICAL STAFF: A SINGLE-ARM PRE-POST INTERVENTION	3
ANXIETY SENSITIVITY BIAS AND COLLECTIVE ACTION PARADOX IN EPIDEMIC PREVENTION AND RESPONSE IN WESTERN COUNTRIES — AN ANALYSIS BASED ON INCOMPLETE INFORMATION LEARNING MODEL	3
RAPID AND SUSTAINED IMPROVEMENT OF RESIDUAL ANHEDONIA SYMPTOMS IN PATIENTS WITH DEPRESSION USING ANALGESIC AGENT - DEZOCINE	3
ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A 30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE	3
CONFLICT EQUILIBRIUM PREFERENCE RANKING OF MULTIPLE DECISION MAKERS BASED ON CONFLICT RESOLUTION GRAPH MODEL AND EMOTION REGULATION	3
551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES	3
379. INCIDENCE OF PSYCHOSIS AND ITS RISK FACTORS AND MORTALITY IN NORTH KOREAN DEFECTORS COMPARED TO SOUTH KOREAN CONTROLS	3
707. EXPERIENCES WITH NITAZENE WITHDRAWAL	3
506. MAPPING PERIPHERAL MOLECULAR MECHANISMS ASSOCIATED WITH LONG-LASTING EFFECTS OF EARLY LIFE STRESS: A TRANSCRIPTOMIC SET-BASED APPROACH	3
505. ROLE OF COGNITIVE FUNCTION IN FUNCTIONAL OUTCOME IN PSYCHOTIC AND AFFECTIVE INPATIENTS	3
AUTOMATED ANALYSIS OF RODENT BEHAVIOR USING INTELLIPROFILLER: A POTENTIAL TOOL FOR STUDYING NEURODEVELOPMENTAL DISORDER-LIKE MODEL MICE	3
Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects	3
519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL	3
702. INNOVATIVE PERSPECTIVES IN NEUROPSYCHOPHARMACOLOGY: INSIGHTS FROM INDONESIA, NEWZEALAND AND AUSTRALIA	3
635. THE NEUROBIOLOGICAL FOUNDATION FOR PHYSICAL EXERCISE RECOMMENDATIONS IN REDUCING SYMPTOMS OF ADHD	3
671. PRENATAL STRESS EXPOSURE SHAPES CORTICOGENESIS THROUGH CELL FATE AND GENE REGULATORY NETWORKS WITH IMPLICATIONS FOR NEURODEVELOPMENTAL DISORDERS	3
555. M4 MUSCARINIC RECEPTOR ACTIVATION IN THE CENTRAL AMYGDALA REDUCES STRESS-INDUCED ALCOHOL SEEKING IN ALCOHOL PREFERRING RATS	3
681. ENDOCANNABINOIDS AND INTRUSIVE MEMORIES: EVIDENCE FOR A ROLE OF ANANDAMIDE FROM TWO EXPERIMENTAL HUMAN STUDIES	2
324. THEORETICAL DRUG SELECTION FOR BPSD	2
201. DISCRIMINATION BETWEEN HEALTHY PARTICIPANTS AND PEOPLE WITH PANIC DISORDER BASED ON POLYGENIC SCORES FOR PSYCHIATRIC DISORDERS AND FOR INTERMEDIATE PHENOTYPES USING MACHINE LEARNING	2
Thrombomodulin Improves Cognitive Deficits in Heat-Stressed Mice	2
ASSOCIATION BETWEEN ADHD, METHYLPHENIDATE, AND PRECOCIOUS PUBERTY: A NATIONWIDE COHORT STUDY	2
347. PREDICTING RTMS TREATMENT RESPONSE IN DEPRESSION: USE OF MACHINE LEARNING MODELS TO IDENTIFY THE ROLES OF METABOLIC AND CLINICAL FACTORS	2
Neurobiological influences on event perception: the role of catecholamines	2
A MACHINE LEARNING APPROACH TO PREDICT THE THERAPEUTIC EFFICACY OF MOBILE NEUROFEEDBACK IN CHILDREN WITH ADHD	2
RESEARCH ON THE INNOVATION OF TEACHING MODE OF “FRESHMAN SEMINAR” IN APPLIED UNIVERSITIES UNDER THE CONCEPT OF OBE BASED ON THE CHANGE OF EMOTIONAL BEHAVIOR -- TAKING PHYSICAL EDUCATION MAJOR OF NANCH	2
Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex	2
Sleep Deprivation Engages the Orexin/Hypocretin System to Regulate Food Reward Seeking	2
437. EVALUATING APELIN AS A POTENTIAL BIOMARKER IN MAJOR DEPRESSIVE DISORDER: CORRELATION WITH CLINICAL SYMPTOMATOLOGY	2
694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING	2
241. NEUROPHYSIOLOGICAL INSIGHTS INTO OMISSION MISMATCH NEGATIVITY: EVIDENCE FROM MACRO CALCIUM IMAGING IN RAT AUDITORY CORTEX	2
THE MODERATING EFFECT OF JOB SEARCH INTENSITY ON POSTGRADUATES' COMPREHENSIVE ABILITY, EMPLOYMENT PERFORMANCE AND PSYCHOLOGICAL ANXIETY SENSITIVITY	2
628. DOPAMINERGIC CONTROL OF COMPULSIVE EATING	2
Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use	2
ELEVATED MIDBRAIN INTERLEUKIN-6 AND IMPAIRED GOAL-DIRECTED BEHAVIOR IN OLD C57BL/6J MICE AFTER HINDLIMB UNLOADING	2
Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies	2
168. EXPLORING SAFE TAPERING OF ANTIPSYCHOTICS IN PATIENTS WITH REMITTED PSYCHOSIS: EMPLOYING ANIMAL MODEL AND COADMINISTRATION OF N-ACETYLCYSTEINE STUDY IN BENCH AND BESIDE	2
PREDICTING RELAPSE FROM THE TIME TO REMISSION DURING THE ACUTE TREATMENT OF DEPRESSION: A RE-ANALYSIS OF THE STAR*D DATA	2
445. DISTINCTIVE ASSOCIATION PATTERNS BETWEEN TOPOLOGICAL PROPERTIES OF BRAIN STRUCTURAL NETWORKS AND SOCIAL COGNITION IN EUTHYMIC BIPOLAR DISORDER	2
STUDY ON THE IMPACT OF JOB SECURITY ON JOB PERFORMANCE AND ANXIETY SENSITIVITY OF GRASS-ROOTS EMPLOYEES IN HIGH STAR HOTELS	2
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential	2
354. COGNITIVE FLEXIBILITY AS A POSSIBLE INDEX OF AGE-RELATED COGNITIVE DECLINE	2
274. RETROSPECTIVE STUDY FOR CORRELATION WITH REDUCING ANTIPARKINSONIAN ANTICHOLINERGIC DRUGS AND ADVERSE EFFECTS	2
488. SALIENCE NETWORK ALTERATIONS RELATED TO PERSONALITY TRAITS IN ADOLESCENTS WITH EXCESSIVE SMARTPHONE USE	2
VITAMIN D AND DEPRESSION	2
ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS AND TARDIVE DYSKINESIA: ANALYSIS BASED ON A SPONTANEOUS REPORTING SYSTEM DATABASE IN JAPAN	2
PRACTICAL GUIDELINES ON THE USE OF CARIPRAZINE IN BIPOLAR 1 DISORDER: EXPERT CONSENSUS FROM SOUTHEAST ASIA	2
367. DISCOVERING MARKERS OF INTRON RETENTION IN DEPRESSION AND ITS RESPONSE TO KETAMINE	2
THE USE OF ZOLPIDEM AND THE RISK OF ARRHYTHMIA: INSIGHTS FROM A NATIONAL SURVEY	2
Corrigendum to: Naturally Derived Polyphenols Protect Against Corticosterone-Induced Changes in Primary Cortical Neurons	2
AN EMPIRICAL STUDY ON CHINESE EFL LEARNERS' CROSS-CULTURAL SENSITIVITY BASED ON EDUCATIONAL EMOTION REGULATION	2
Illicit substance exposure in pregnancy and infant mortality risk: a nationwide Taiwan study	2
307. THE EFFECT OF SODIUM BENZOATE TREATMENT FOR TREATMENT RESISTANT SCHIZOPHRENIA AND ITS ASSOCIATION WITH GLUTAMATE CONCENTRATION: A PILOT STUDY WITH PROTON MAGNETIC RESONANCE SPECTROSCOPY	2
643. RESTING-STATE FUNCTIONAL CONNECTIVITY ASSOCIATIONS WITH SUICIDAL IDEATION SEVERITY IN TREATMENT-RESISTANT DEPRESSION	2
690. SERUM ELEMENTS AND OXIDATIVE STRESS INDICES ARE ALTERED IN TREATMENT-RESISTANT SCHIZOPHRENIA	1
591. MUSCARINIC RECEPTORS AND THE MOLECULAR PATHOLOGY OF SCHIZOPHRENIA	1
363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR	1
EFFECTS OF SMOKING CUES ON CORTICOSTRIATAL GLUTAMATE LEVELS IN NON-SMOKERS	1
Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers	1
A CASE STUDY OF COMPREHENSIVE TREATMENT ON GAMBLING DISORDER IN ADOLESCENTS: NOVEL CHALLENGES IN LOW MIDDLE INCOME COUNTRY	1
THE STATUS OF HOPELESSNESS AND RELATED FACTORS IN KOREAN FEMALE FULL-TIME HOMEMAKERS: A COMMUNITY-BASED CROSS- SECTIONAL SURVEY STUDY	1
EXPERT APPRAISAL OF CRITERIA FOR NON-HUMAN PRIMATE MODEL FOR ADDICTION: AN INTERNATIONAL DELPHI STUDY	1
REGION-SPECIFIC PLASTIC CHANGES IN THE PREFRONTAL CORTEX DRIVE COMPULSIVE TASK PERFORMANCE	1
305. CT-152, A PRESCRIPTION DIGITAL THERAPEUTIC FOR MAJOR DEPRESSIVE DISORDER: A REAL-WORLD ANALYSIS OF DURABILITY OF TREATMENT EFFECT	1
234. ANXIETY BEHAVIOR AND IMMUNE RESPONSE OF MICROGLIA IN RATS SUBJECTED TO STRESS THROUGH THE SYMPATHETIC NERVOUS SYSTEM	1
Five-factor personality traits in patients with schizophrenia and bipolar disorder: A systematic review and meta-analysis	1
RELATIONSHIP BETWEEN MORNING BLOOD MELATONIN LEVELS AND SLEEP PROBLEMS IN 5-YEAR-OLD CHILDREN WITH ASD	1
SLOVAK PSYCHIATRISTS‘PERSPECTIVE ON THE ROLE OF PHARMACOGENETIC TESTING IN MENTAL HEALTH CARE	1
Corrigendum to: A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical An	1
DID USE OF ELECTRONIC CIGARETTES AND SMOKELESS TOBACCO BY BELARUSIAN TEENAGERS AND YOUNG ADULTS HAS URGING AND AGGRAVATING OR PREVENTIVE AND REPLACEMENT PUBLIC HEALTH EFFECT ON TOBACCO SMOKING?	1
INVESTIGATION OF THE LONG-TERM EFFECTS OF LEMBOREXANT ON OBJECTIVE SLEEP MEASURES USING A MINIATURE ELECTROENCEPHALOGRAM	1
TRANSCRANIAL PULSE STIMULATION FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A RANDOMIZED, DOUBLE-BLIND, SHAM- CONTROLLED, PILOT TRIALS	1
INVESTIGATING THE EFFECTS OF PRIMING THETA BURST STIMULATION IN HEALTHY AND SUBCLINICALLY DEPRESSED POPULATIONS	1
630. EPITRANSCRIPTOMIC REGULATION OF STRIATAL FUNCTION: A NEW NEUROBIOLOGY OF SCHIZOPHRENIA?	1
509. INVOLVEMENT OF THE GUT-BRAIN AXIS IN FOOD ADDICTION	1
Anhedonia is associated with a specific depression profile and poor antidepressant response	1
Retraction of: Mesenchymal Stem Cell–Derived Extracellular Vesicles Alleviate M1 Microglial Activation in Brain Injury of Mice With Subarachnoid Hemorrhage via microRNA-140-5p Delivery	1
Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects	1
IS TIME PERSPECTIVE A PREDICTOR FOR EDUCATIONAL ASPIRATIONS?	1
DRUG-RESPONSE RELATIONSHIP OF ESCITALOPRAM IN OBSESSIVE COMPULSIVE DISORDER BASED ON TREATMENT OUTCOME: A PHARMACOKINETIC-PHARMACODYNAMIC MODELING APPROACH	1
REPURPOSING OF GAMMA-HYDROXYBUTYRATE IN DEPRESSION: A RANDOMIZED PLACEBO-CONTROLLED PROOF-OF-CONCEPT CLINICAL TRIAL	1
IS THERE AN OPTIMAL ELECTRODE PLACEMENT FOR PATIENTS WITH SCHIZOPHRENIA UNDERGOING ELECTROCONVULSIVE THERAPY?	1